At a Glance United Therapeutics’ (NASDAQ:UTHR) Q2 performance underscores robust financials with a notable 27.7% YoY revenue increase, fueling investor optimism. On the clinical
Retirement income systems vary in different countries, and the U.S. does not come out on top. Klaus Vedfelt | Digitalvision | Getty Images Long-awaited